Mojgan Tavakoli, DPM
Podiatrist · Frisco, TXNPI 1801847694
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $51,457 of the $78,780 with a category attached, or 65.3%. Treace Medical Concepts, Inc. accounts for 83.5% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2023 at $35,573 and has fallen 92.4% since, to $2,721 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 291 payments — averaging $270.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$66K
- Arthrex$4K
- Pylant Medical$3K
- Stryker$1K
- Medical Device Business Services, Inc.$969
- Paragon 28, Inc.$831
- plus $3K from 30 others
What the payments were for
- Consulting fees$51,45765%
- Travel & lodging$12,85516%
- Food & beverage$9,68512%
- Education$4,7836%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 95 | $65,776 |
| Arthrex | 17 | $3,600 |
| Pylant Medical | 13 | $2,767 |
| Stryker(2 entities) | 26 | $1,399 |
| Medical Device Business Services, Inc. | 6 | $969 |
| Paragon 28, Inc. | 3 | $831 |
| Nevro Corp. | 10 | $496 |
| Smith+Nephew | 17 | $471 |
| Amgen(2 entities) | 8 | $357 |
| Johnson & Johnson | 10 | $319 |
| Integra Lifesciences Corporation | 2 | $276 |
| Pacira Pharmaceuticals Incorporated | 5 | $199 |
| Orthofix Medical, Inc. | 22 | $194 |
| Osteoremedies, LLC | 1 | $153 |
| Paratek Pharmaceuticals, Inc. | 7 | $135 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $125 |
| Anika Therapeutics, Inc. | 1 | $117 |
| Sandoz | 13 | $115 |
| Melinta Therapeutics, LLC | 4 | $77 |
| IBSA Pharma Inc. | 5 | $76 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $30 |
| Averitas Pharma Inc. | 1 | $30 |
| Glenmark Therapeutics Inc. | 2 | $29 |
| Zimmer Biomet | 1 | $26 |
| Bsn Medical Inc | 2 | $25 |
| Nabriva Therapeutics, PLC | 2 | $25 |
| Organogenesis Inc. | 1 | $23 |
| Vertex | 1 | $22 |
| Assertio Therapeutics, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Nvision Biomedical Technologies, Inc. | 1 | $16 |
| Biotissue Holdings Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Abbott | 1 | $13 |
| Tactile Systems Technology Inc | 1 | $12 |
| Amniox Medical, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$62,723
- VA-LCP PLATES & SCREWS$779
- PERCUPLASTY TRAY$593
- CYTAL$517
- Omnia$357
- AUGMENT INJECTABLE$254
- LAPIPLASTY SYSTEM 1$251
- KRYSTEXXA$250
- TMC PSI CUT GUIDE SYSTEM$212
- BlastX$153
- Xperience$153
- TMC NANOPLASTY SYSTEM$145
- SALVATION$141
- Bone Anchors with Arthroscopic Delivery System$139
- PROPHECY$138
- VALOR$138
- INBONE$137
- TACTOSET$117
- BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$110
- CLAW II$106
How this compares
$78,780 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 18 | $13,286 |
| EliquisApixaban | 17 | $9,434 |
| Tavaborole | 14 | $3,256 |
| CiclopiroxCiclopirox Olamine | 150 | $2,363 |
| Cephalexin | 13 | $515 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 66 | $484 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $419 |
| Ondansetron OdtOndansetron | 37 | $409 |
| Fluconazole | 29 | $212 |
| Clindamycin Hcl | 27 | $172 |
| Ibuprofen | 20 | $139 |
| Celecoxib | 11 | $117 |
| Amoxicillin | 31 | $112 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $101 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $90 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $125 | $13,28618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 470 podiatrist providers in Texas.
Other podiatrist in Frisco
- Robert TaylorFrisco$99K
- Horst KnappFrisco$15K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.